Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACC017 in Treatment-Experienced Adults With NNRTI-Resistant HIV-1
NCT07711210Phase 2Active, not recruiting
- Sponsor
- Aidea Pharma
- Start
- Mar 2025
- Primary completion
- Jun 2027
- Countries
- 1
01
Overview
A Phase 2 trial of asuptegravir in human immunodeficiency virus infection (HIV), sponsored by Aidea Pharma. Started Mar 2025; status: active, not recruiting.
02
Drugs
asuptegravir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT07711210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07711210.